CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Spectrum Pharmaceuticals, Inc. v. Eurohealth International Sarl

2:14-cv-00980

Overview

Case Number 2:14-cv-00980
Filing Date 2014-06-18
Status Terminated
Termination Date 2016-06-09
Court District Court, D. Nevada (nvd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

West-Ward Pharmaceutical Corp. Operating Company

Represented By

4 Attorneys Listed

Eurohealth International Sarl NPE (Individual / Inventor)

Represented By

4 Attorneys Listed

Spectrum Pharmaceuticals, Inc. Operating Company

Represented By

9 Attorneys Listed

Counter Defendant

University of Strathclyde NPE (University / Research)

Represented By

9 Attorneys Listed

Consolidated Defendant

Ben Venue Laboratories, Inc. Operating Company

Represented By

4 Attorneys Listed

Court & Judges

Court

District Court, D. Nevada (nvd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 11 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (11): GB 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6500829
Substantially pure diastereoisomers of tetrahydrofolate derivatives
Filed: 1995-04-18
Issued: 2002-12-31
Expired (Term Ended) +2515d PTA
Expires: 2022-03-07

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+2515 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

4

Dispositive

0

Granted

1

Denied

0

Pending / Review

3

Motions by Category

Claim Construction / Markman Filing 2 Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Granted
ORDER granting 45 Joint Motion to Substitute Party and Plaintiffs' Motion for Leave to file First Amended Complaint. Pursuant to Federal Rule of Civil P...
Entry #48 • 2014-11-24 Document →
Procedural / Extension Motion Pending / Under Review
NOTICE of Attorney Action Required: to 45 Joint MOTION to Substitute Party: ERROR: Documents should have been filed as separate entries by attorney John Randolp...
Entry #46 • 2014-11-21 Document →
Claim Construction / Markman Filing Pending / Under Review
ORDER ON STIPULATION granting 40 STIPULATION Regarding Claim Construction. Signed by Magistrate Judge Peggy A. Leen on 10/17/2014. (Copies have been distributed...
Entry #42 • 2014-10-20 Document →
Claim Construction / Markman Filing Pending / Under Review
STIPULATION re 38 Scheduling Order ; Stipulation and [Proposed] Order Regarding Claim Construction by Defendant Ben Venue Laboratories, Inc., Plaintiffs Spectru...
Entry #40 • 2014-10-14 Document →

Docket Entries

(63 total)
Pleading / Complaint

COMPLAINT for Patent Infringement against Ben Venue Laboratories, Inc. (Filing fee $400 receipt number 0978-3280362), filed by Spectrum Pharmaceuticals, Inc., University of Strathclyde. Certificate of Interested Parties due by 6/28/2014. Proof of service due by 10/16/2014. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet, # 3 Summons) (Fountain, Jonathan) (Entered: 06/18/2014)

Entry #1 • 2014-06-18
1
Pleading / Complaint

COMPLAINT for Patent Infringement against Ben Venue Laboratories, Inc. (Filing fee $400 receipt number 0978-3280362), filed by Spectrum Pharmaceuticals, Inc., University of Strathclyde. Certificate of Interested Parties due by 6/28/2014. Proof of service due by 10/16/2014. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet, # 3 Summons) (Fountain, Jonathan) (Entered: 06/18/2014)

Entry #1 • 2014-06-18
2
Pleading / Complaint

COMPLAINT for Patent Infringement against Ben Venue Laboratories, Inc. (Filing fee $400 receipt number 0978-3280362), filed by Spectrum Pharmaceuticals, Inc., University of Strathclyde. Certificate of Interested Parties due by 6/28/2014. Proof of service due by 10/16/2014. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet, # 3 Summons) (Fountain, Jonathan) (Entered: 06/18/2014)

Entry #1 • 2014-06-18
2
Pleading / Complaint

COMPLAINT for Patent Infringement against Ben Venue Laboratories, Inc. (Filing fee $400 receipt number 0978-3280362), filed by Spectrum Pharmaceuticals, Inc., University of Strathclyde. Certificate of Interested Parties due by 6/28/2014. Proof of service due by 10/16/2014. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet, # 3 Summons) (Fountain, Jonathan) (Entered: 06/18/2014)

Entry #1 • 2014-06-18
2
Court Order

NOTICE PURSUANT TO LOCAL RULE IB 2-2: In accordance with 28 USC § 636(c) and FRCP 73, the parties in this action are provided with a link to the "AO 85 Notice of Availability, Consent, and Order of Reference - Exercise of Jurisdiction by a U.S. Magistrate Judge" form on the Court's website - www.nvd.uscourts.gov. AO 85 Consent forms should NOT be electronically filed. Upon consent of all parties, counsel are advised to manually file the form with the Clerk's Office. (A copy of form AO 85 has been mailed to parties not receiving electronic service.)NOTICE OF GENERAL ORDER 2013-1 AND OPPORTUNITY FOR EXPEDITED TRIAL SETTING: The parties in this action are provided with a link to General Order 2013-1 and the USDC Short Trial Rules on the Court's website - www.nvd.uscourts.gov. If the parties agree that this action can be ready for trial within 180 days and that a trial of this matter would take three (3) days or less, the parties should consider participation in the USDC Short Trial Program. If the parties wish to be considered for entry into the Court's Short Trial Program, they should execute and electronically file with USDC Short Trial Form 4(a)(1) or Form 4(a)(2). (no image attached) (ASB) (Entered: 06/18/2014)

Entry #2 • 2014-06-18
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc